Evaluation of cardiac structure by echoreflectivity analysis in acromegaly: effects of treatment

被引:10
作者
Ciulla, MM
Epaminonda, P
Paliotti, R
Barelli, MV
Ronchi, C
Cappiello, V
Sartorio, A
Buonamici, V
Magrini, F
Beck-Peccoz, P
Arosio, M
机构
[1] Osped San Giuseppe, Unita Endocrinol, UO Endocrinol, I-20123 Milan, Italy
[2] Ctr Interuniv Fisiol Clin & Ipertens, Ist Med Cardiovasc & Terapia Med, Milan, Italy
[3] Univ Milan, Osped Maggiore, IRCCS, Ist Sci Endocrine, Milan, Italy
[4] IRCCS, Ist Auxol Italiano, LSRE, Div Malattie Metab 3, Milan, Italy
关键词
D O I
10.1530/eje.0.1510179
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Cardiac echoreflectivity is a noninvasive tool for evaluating cardiac fibrosis. The present paper aimed to study the modifications of cardiac echoreflectivity in a group of acromegalic patients before and after therapy, and to assess possible correlations with serum levels of procollagen III (PIIINP), a peripheral index of collagen synthesis. Design and methods: Cardiac echoreflectivity (as assessed by analyzing 2-D echocardiograms digitized off-line onto a personal computer) and PIIINP levels were evaluated in 16 acromegalic patients of new diagnosis not affected by arterial hypertension (10 males, six females, age+/-S.D.: 38+/-10 years), and in a group of 16 sex- and age-matched healthy subjects. All the patients were re-evaluated after surgical and/or medical therapy for acromegaly. The echo patterns were analyzed by software that supplies the derived collagen volume fraction (dCVF), an index of fibrosis. Results: At baseline, acromegalic patients showed significantly higher dCVF values and PIIINP levels than healthy controls (3.1 +/- 0.5% vs 1.6 +/- 0.3%, P < 0.01 and 8.7 +/- 2.2 vs 3.1 +/- 1.1 ng/ml, P < 0.05, respectively, by unpaired Student's t-test). After therapy, dCVF and PIIINP levels normalized in the six controlled patients (that is, GH of < 2.5 mug/l and IGF-I within normal range) (dCVF from 2.8 +/- 0.4% to 1.4 +/- 0.2%. P < 0.001; PIIINP from 8 +/- 2.7 to 3.3 +/- 1.9 ng/ml, P < 0.05), while no significant changes were found in noncontrolled patients (dCVF from 3.3 +/- 0.6% to 2.9 +/- 1.2% and PIIINP from 9.1 +/- 1.9 to 7.9 +/- 3.5 ng/ml, P = NS). A positive correlation between dCVF and PIIINP (r = 0.75. P < 0.001) and between IGF-I and both dCVF and PIIINP (r = 0.65 and 0.61 respectively, P < 0.05) was found in acromegalic patients. Conclusions: Cardiac echoreflectivity, which may be a reflection of heart collagen content, is increased m patients with active acromegaly and correlates with PIIINP concentrations. After cure or adequate control of the disease, both parameters revert to normal. Echoreflectivity analysis could be a useful adjuvant parameter in the assessment of the activity of acromegalic disease.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 31 条
[1]   Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency [J].
Bollerslev, J ;
Moller, J ;
Thomas, S ;
Djoseland, O ;
Christiansen, JS .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 135 (06) :666-671
[2]   Echocardiographic patterns of myocardial fibrosis in hypertensive patients: Endomyocardial biopsy versus ultrasonic tissue characterization [J].
Ciulla, M ;
Paliotti, R ;
Hess, DB ;
Tjahja, E ;
Campbell, SE ;
Magrini, F ;
Weber, KT .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 1997, 10 (06) :657-664
[3]   Blood pressure-independent cardiac hypertrophy in acromegalic patients [J].
Ciulla, M ;
Arosio, M ;
Barelli, MV ;
Paliotti, R ;
Porretti, S ;
Valentini, P ;
Tortora, G ;
Buonamici, V ;
Moraschi, A ;
Cappiello, V ;
Magrini, F .
JOURNAL OF HYPERTENSION, 1999, 17 (12) :1965-1969
[4]   Effects of thyroid hormones on cardiac structure: A tissue characterization study in patients with thyroid disorders before and after treatment [J].
Ciulla, MM ;
Paliotti, R ;
Cortelazzi, D ;
Tortora, G ;
Barelli, MV ;
Buonamici, V ;
Magrini, F ;
Beck-Peccoz, P .
THYROID, 2001, 11 (07) :613-619
[5]   Cardiovascular function in acromegaly [J].
Clayton, RN .
ENDOCRINE REVIEWS, 2003, 24 (03) :272-277
[6]   Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance [J].
Colao, A ;
Cuocolo, A ;
Marzullo, P ;
Nicolai, E ;
Ferone, D ;
Morte, AMD ;
Pivonello, R ;
Salvatore, M ;
Lombardi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1551-1557
[7]   Growth hormone and the heart [J].
Colao, A ;
Marzullo, P ;
Di Somma, C ;
Lombardi, G .
CLINICAL ENDOCRINOLOGY, 2001, 54 (02) :137-154
[8]   RELATIONSHIP OF PROCOLLAGEN TYPE-III PROPEPTIDE-RELATED ANTIGENS IN SERUM TO SOMATIC GROWTH IN HEALTHY-CHILDREN AND PATIENTS WITH GROWTH DISORDERS [J].
DANNE, T ;
GRUTERS, A ;
SCHUPPAN, D ;
QUANTAS, N ;
ENDERS, I ;
WEBER, B .
JOURNAL OF PEDIATRICS, 1989, 114 (02) :257-260
[9]  
DEVEREUX RB, 1987, HYPERTENSION, V9, P19
[10]   EVIDENCE FOR BIVENTRICULAR INVOLVEMENT IN ACROMEGALY - A DOPPLER ECHOCARDIOGRAPHIC STUDY [J].
FAZIO, S ;
CITTADINI, A ;
SABATINI, D ;
MEROLA, B ;
COLAO, AM ;
BIONDI, B ;
LOMBARDI, G ;
SACCA, L .
EUROPEAN HEART JOURNAL, 1993, 14 (01) :26-33